These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies. Sureda A; Schmitz N Ann Hematol; 2003 Jan; 82(1):1-13. PubMed ID: 12574957 [TBL] [Abstract][Full Text] [Related]
26. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991 [TBL] [Abstract][Full Text] [Related]
27. [Non-myeloablative allogeneic stem cell transplantation]. Dalgaard J; Fløisand Y; Stenersen M; Egeland T; Brinch L Tidsskr Nor Laegeforen; 2007 Mar; 127(6):721-4. PubMed ID: 17363982 [TBL] [Abstract][Full Text] [Related]
28. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [TBL] [Abstract][Full Text] [Related]
31. Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT). Poiré X; Labopin M; Cornelissen JJ; Volin L; Richard Espiga C; Veelken JH; Milpied N; Cahn JY; Yacoub-Agha I; van Imhoff GW; Michallet M; Michaux L; Nagler A; Mohty M Am J Hematol; 2015 Aug; 90(8):719-24. PubMed ID: 26010466 [TBL] [Abstract][Full Text] [Related]
32. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors. Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651 [TBL] [Abstract][Full Text] [Related]
33. Reconstitution of the Ig heavy chain CDR3 repertoire after allogeneic haematopoietic stem cell transplantation with myeloablative or reduced-intensity conditioning regimens. Omazic B; Hentschke P; Näsman-Björk I; Mattsson J; Oxelius VA; Ringdén O; Barkholt L; Permert J; Lundkvist I Scand J Immunol; 2005 Jan; 61(1):72-81. PubMed ID: 15644125 [TBL] [Abstract][Full Text] [Related]
34. Allogeneic haematopoietic stem cell transplantation: current status and future outlook. Aschan J Br Med Bull; 2006; 77-78():23-36. PubMed ID: 16968691 [TBL] [Abstract][Full Text] [Related]